Association study of the TNF-α -1031T/C and VEGF+450G/C polymorphisms with susceptibility to endometriosis

Gynecological Endocrinology

Volumn 29, Issue 11, 2013, Pages 974-977

  Saliminejad, Kioomars ^a   Memariani, Toktam ^a   Ardekani, Ali M ^a   Kamali, Koorosh ^a   Edalatkhah, Haleh ^a   Pahlevanzadeh, Zhamak ^a   Khorram Khorshid, Hamid Reza ^b  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Endometriosis; PCR RFLP; Polymorphism; TNF ; VEGF

Indexed keywords

GENOMIC DNA; RESTRICTION ENDONUCLEASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

5' UNTRANSLATED REGION; ADULT; ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADULT; ALLELES; BODY MASS INDEX; CASE-CONTROL STUDIES; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFERTILITY, FEMALE; IRAN; MIDDLE AGED; OVERWEIGHT; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84885065341     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2013.824956     Document Type: Article

References (24)

1. Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789-99.
2. Berkley KJ, Rapkin AJ, Papka RE. The pains of endometriosis. Science 2005; 308: 587-9.
3. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997; 24: 235-58.
4. Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assist Reprod Genet 1995; 12: 32-4.
5. Simpson JL, Bischoff FZ. Heritability and molecular genetic studies of endometriosis. Ann N Y Acad Sci 2002; 955: 239-51; discussion 93-5, 396-406.
6. Montgomery GW, Nyholt DR, Zhao ZZ, et al. The search for genes contributing to endometriosis risk. Hum Reprod Update 2008; 14: 447-57.
7. Keenan JA, Chen TT, Chadwell NL, et al. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am J Reprod Immunol 1995; 34: 381-5.
8. Braun DP, Gebel H, House R, et al. Spontaneous and induced synthesis of cytokines by peripheral blood monocytes in patients with endometriosis. Fertil Steril 1996; 65: 1125-9.
9. Asghar T, Yoshida S, Kennedy S, et al. The tumor necrosis factoralpha promoter -1031C polymorphism is associated with decreased risk of endometriosis in a Japanese population. Hum Reprod 2004; 19: 2509-14.
10. McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 2000; 6: 45-55.
11. Bhanoori M, Arvind Babu K, Pavankumar Reddy NG, et al. The vascular endothelial growth factor (VEGF)p405G4C 50-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod 2005; 20: 1844-9.
12. Kim SH, Choi YM, Choung SH, et al. Vascular endothelial growth factor gene p405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod 2005; 20: 2904-8.
13. Zondervan KT, Cardon LR, Kennedy SH. What makes a good casecontrol study? Design issues for complex traits such as endometriosis. Hum Reprod 2002; 17: 1415-23.
14. Tempfer CB, Simoni M, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: part IIendometriosis. Hum Reprod Update 2009; 15: 97-118.
15. Agic A, Xu H, Finas D, et al. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006; 62: 139-47.
16. Hsieh YY, Chang CC, Tsai FJ, et al. Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: non-association with endometriosis. J Clin Lab Anal 2002; 16: 121-6.
17. Lee MK, Park AJ, Kim DH. Tumor necrosis factor-alpha and interleukin-6 promoter gene polymorphisms are not associated with an increased risk of endometriosis. Fertil Steril 2002; 77: 1304-5.
18. Wieser F, Fabjani G, Tempfer C, et al. Tumor necrosis factor-alpha promoter polymorphisms and endometriosis. J Soc Gynecol Investig 2002; 9: 313-8.
19. Teramoto M, Kitawaki J, Koshiba H, et al. Genetic contribution of tumor necrosis factor (TNF)-alpha gene promoter (-1031, -863 and -857) and TNF receptor 2 gene polymorphisms in endometriosis susceptibility. Am J Reprod Immunol 2004; 51: 352-7.
20. Zhao ZZ, Nyholt DR, Le L, et al. Genetic variation in tumour necrosis factor and lymphotoxin is not associated with endometriosis in an Australian sample. Hum Reprod 2007; 22: 2389-97.
21. Ikuhashi Y, Yoshida S, Kennedy S, et al. Vascular endothelial growth factor p936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population. Acta Obstet Gynecol Scand 2007; 86: 1352-8.
22. Gentilini D, Somigliana E, Vigano P, et al. The vascular endothelial growth factor p405G4C polymorphism in endometriosis. Hum Reprod 2008; 23: 211-5.
23. Emamifar B, Salehi Z, Mehrafza M, Mashayekhi F. The vascular endothelial growth factor (VEGF) polymorphisms and the risk of endometriosis in northern Iran. Gynecol Endocrinol 2012; 28: 447-50.
24. Liang S, Huang Y, Fan Y. Vascular endothelial growth factor gene polymorphisms and endometriosis risk: a meta-analysis. Arch Gynecol Obstet 2012; 286: 139-46.